| abstract |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole, for example, pharmaceutically acceptable salts of compounds of formula IA useful for the modulation of kinase activity in COPD, and pharmaceutical compositions thereof, Lt; / RTI > Also provided herein are methods of using, treating, ameliorating, or ameliorating one or more symptoms of an RC kinase-mediated disorder, disease, or condition. |